TG Therapeutics
TGTX
TGTX
235 hedge funds and large institutions have $762M invested in TG Therapeutics in 2023 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 100 increasing their positions, 51 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 244 → 235 (-9)
13% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 54
65% less capital invested
Capital invested by funds: $2.19B → $762M (-$1.43B)
Holders
235
Holding in Top 10
3
Calls
$25.3M
Puts
$24M
Top Buyers
| 1 | +$35M | |
| 2 | +$30.3M | |
| 3 | +$20.5M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$15.8M |
| 5 |
6CM
683 Capital Management
New York
|
+$11.3M |
Top Sellers
| 1 | -$230M | |
| 2 | -$43.1M | |
| 3 | -$40.4M | |
| 4 |
Alkeon Capital Management
New York
|
-$38.4M |
| 5 |
Man Group
London,
United Kingdom
|
-$17.1M |